Menu

Pharmaceutical Litigation

855-797-9899

Pharmaceutical Litigation

Complications
after taking
Onglyza®?

Find out if you qualify
for legal recourse through
a FREE, private and no
obligation
case review by our Pharma Suits
patient advocates.

Free Case Review




Onglyza and The SAVOR Study

Onglyza, the pharmaceutical giant AstraZeneca’s brand name for the type 2 (non-insulin-dependent) diabetes drug saxagliptin, was approved by the U.S. Food and Drug Administration (FDA) in 2009. Since that time, it has been prescribed to millions of Americans. Onglyza is in a class of drugs called incretin mimetics that work by imitating the incretin hormones a body produces to stimulate insulin release after eating. But, since its approval, Onglyza has come under increased scrutiny due to reported side effects and links suggested between the medication and heart failure, pancreatitis, pancreatic cancer, and thyroid cancer.

If you or a family member has been prescribed Onglyza or the similar drugs Januvia, Trajenta, Combiglyze, Janumet, and Jentadueto, and experienced any side effects whatsoever, you need to contact a personal injury attorney. The legal team at the law offices of Farah & Farah has been successfully representing injury victims for over 35 years. We are now investigating Onglyza injury cases nationwide. Let us put our determination, skill, and knowledge behind your case and get you the settlement you deserve.

Call the Onglyza injury lawyers at Farah & Farah today at (800) 533-3555 for a free consultation.

Side Effects Associated with Onglyza Use

Patients treated with Onglyza have reported a myriad of side effects in addition to the aforementioned chronic pancreatitis, cardiovascular disease, pancreatic and thyroid cancer. These side effects include:

  • Sore throat
  • Headaches
  • Coughing
  • Runny or stuffy nose
  • Upper abdominal pain that spreads to your back
  • Painful or burning urination
  • Swelling of the feet, ankles, and hands
  • Excessive bleeding and bruising

The SAVOR Study

Due to suggested links between Onglyza treatment and heart failure, the FDA commissioned what is referred to as the SAVOR study. SAVOR is an acronym for Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus. SAVOR can be described as a large, double-blind, randomized, placebo controlled study to evaluate the cardiovascular effects of Onglyza in adult patients with type 2 diabetes who are also at risk for cardiovascular disease.

The study involved 16,000 patients divided into a control group and a treatment group. When the FDA’s advisory committee met to review the data from the SAVOR study, they found that the group being treated with Onglyza was more likely to be hospitalized for heart failure than the group that wasn’t treated with Onglyza. In fact, the data suggested that the Onglyza treatment group was 27 percent more at risk of being hospitalized due to heart failure than the control group. That makes Onglyza users over one quarter more likely to experience a cardiovascular episode. The committee also found an increase in “all cause mortality among those treated with Onglyza.”

However, the FDA committee found the cardiovascular risks of Onglyza acceptable and did not recommend that the drug not be pulled off the market or have its use restricted. They did, though, recommend that the drug’s packaging and label include information about an increased risk for heart failure.

Damages for Heart Failure Related to Onglyza Use

If you or a family member has suffered heart failure while being treated with Onglyza, you or they could be entitled to compensation for any of the following damages:

  • All related medical bills – past, present, and future
  • Pain and suffering
  • Mental anguish and emotional duress
  • Permanent injury or disability
  • Costs of physical therapy and rehabilitation
  • Vehicle and household modifications if necessary
  • Lost wages
  • Loss of career or earning capacity
  • Reduction of earning capacity
  • Loss of joy of life
  • Punitive damages

In the unfortunate event that you’ve lost a loved one who suffered heart failure while being treated with Onglyza, you and your family may be entitled to the following wrongful death damages:

  • Funeral and burial expenses
  • Pain and suffering of the deceased prior to death
  • Medical bills
  • Mental anguish and emotional duress
  • Loss of future income
  • Loss of future benefits, such as medical and retirement benefits
  • Loss of love, affection, friendship, guidance, marital consortium, etc.
  • Loss of household duties the deceased performed, such as childcare, repairs, accounting, property and vehicle maintenance, chores, etc.
  • Punitive damages

Contact Our Onglyza Lawyers Today

The attorneys at the law offices of Farah & Farah sincerely hope you never need our services, but if you ever do, we will consider it an honor to represent you and your family. Pharmaceutical companies and their insurers aren’t going to just hand you the settlement you deserve, they’re going to make you fight for it. You and your family have already suffered enough, let Farah & Farah fight the good fight for you. Farah & Farah is currently investigating nationwide Onglyza injury claims. Call (800) 533-3555 today for a free case evaluation.


Need help now? Speak with a
Patient Advocate now:
855-797-9899

Who We Are

The pharmaceutical litigation attorneys at Farah & Farah go after negligent corporations that put unsuspecting consumers in harm's way. Pharmaceutical companies not only have a duty to manufacture drugs that are safe, but they also have the obligation to warn consumers regarding dangerous side effects that can be caused by these drugs.

Learn More